Biblio

Export 3288 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
R. E. Amariglio, Buckley, R. F., Rabin, J. S., Papp, K. V., Quiroz, Y. T., Mormino, E. C., Sparks, K. P., Johnson, K. A., Rentz, D. M., and Sperling, R. A., “Examining Cognitive Decline Across Black and White Participants in the Harvard Aging Brain Study.”, J Alzheimers Dis, vol. 75, no. 4, pp. 1437-1446, 2020.
C. T. Ambrose, “The Role of Capillaries in the Lesser Ailments of Old Age and in Alzheimer's Disease and Vascular Dementia: The Potential of Pro-Therapeutic Angiogenesis.”, J Alzheimers Dis, vol. 54, no. 1, pp. 31-43, 2016.
D. G. Amen, Egan, S., Meysami, S., Raji, C. A., and George, N., “Patterns of Regional Cerebral Blood Flow as a Function of Age Throughout the Lifespan.”, J Alzheimers Dis, 2018.
D. G. Amen, Trujillo, M., Keator, D., Taylor, D. V., Willeumier, K., Meysami, S., and Raji, C. A., “Gender-Based Cerebral Perfusion Differences in 46,034 Functional Neuroimaging Scans.”, J Alzheimers Dis, vol. 60, no. 2, pp. 605-614, 2017.
D. G. Amen, Wu, J., George, N., and Newberg, A., “Patterns of Regional Cerebral Blood Flow as a Function of Obesity in Adults.”, J Alzheimers Dis, vol. 77, no. 3, pp. 1331-1337, 2020.
D. G. Amen, Harris, W. S., Kidd, P. M., Meysami, S., and Raji, C. A., “Quantitative Erythrocyte Omega-3 EPA Plus DHA Levels are Related to Higher Regional Cerebral Blood Flow on Brain SPECT.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1189-1199, 2017.
D. G. Amen, Taylor, D. V., Meysami, S., and Raji, C. A., “Deficits in Regional Cerebral Blood Flow on Brain SPECT Predict Treatment Resistant Depression.”, J Alzheimers Dis, vol. 63, no. 2, pp. 529-538, 2018.
D. G. Amen, Darmal, B., Raji, C. A., Bao, W., Jorandby, L., Meysami, S., and Raghavendra, C. S., “Discriminative Properties of Hippocampal Hypoperfusion in Marijuana Users Compared to Healthy Controls: Implications for Marijuana Administration in Alzheimer's Dementia.”, J Alzheimers Dis, vol. 56, no. 1, pp. 261-273, 2017.
D. G. Amen, Krishnamani, P., Meysami, S., Newberg, A., and Raji, C. A., “Classification of Depression, Cognitive Disorders, and Co-Morbid Depression and Cognitive Disorders with Perfusion SPECT Neuroimaging.”, J Alzheimers Dis, vol. 57, no. 1, pp. 253-266, 2017.
D. G. Amen, Willeumier, K., Omalu, B., Newberg, A., Raghavendra, C., and Raji, C. A., “Perfusion Neuroimaging Abnormalities Alone Distinguish National Football League Players from a Healthy Population.”, J Alzheimers Dis, vol. 53, no. 1, pp. 237-41, 2016.
A. Amlie-Wolf, Tang, M., Way, J., Dombroski, B., Jiang, M., Vrettos, N., Chou, Y. - F., Zhao, Y., Kuzma, A., Mlynarski, E. E., Leung, Y. Yee, Brown, C. D., San Wang, L. -, and Schellenberg, G. D., “Inferring the Molecular Mechanisms of Noncoding Alzheimer's Disease-Associated Genetic Variants.”, J Alzheimers Dis, vol. 72, no. 1, pp. 301-318, 2019.
J. A. Amorim, Canas, P. M., Tomé, A. R., Rolo, A. P., Agostinho, P., Palmeira, C. M., and Cunha, R. A., “Mitochondria in Excitatory and Inhibitory Synapses have Similar Susceptibility to Amyloid-β Peptides Modeling Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 2, pp. 525-536, 2017.
H. An, Choi, B., Park, K. - W., Kim, D. - H., Yang, D. - W., Hong, C. Hyung, Kim, S. Yoon, and Han, S. - H., “The Effect of Escitalopram on Mood and Cognition in Depressive Alzheimer's Disease Subjects.”, J Alzheimers Dis, vol. 55, no. 2, pp. 727-735, 2017.
H. An, Cho, M. - H., Kim, D. - H., Chung, S., and Yoon, S. - Y., “Orexin Impairs the Phagocytosis and Degradation of Amyloid-β Fibrils by Microglial Cells.”, J Alzheimers Dis, vol. 58, no. 1, pp. 253-261, 2017.
S. Anand, Barnes, J. M., Young, S. A., Garcia, D. M., H Tolley, D., Kauwe, J. S. K., and Graves, S. W., “Discovery and Confirmation of Diagnostic Serum Lipid Biomarkers for Alzheimer's Disease Using Direct Infusion Mass Spectrometry.”, J Alzheimers Dis, vol. 59, no. 1, pp. 277-290, 2017.
M. Anderson, Xu, F., Ou-Yang, M. - H., Davis, J., Van Nostrand, W. E., and Robinson, J. K., “Intensive 'Brain Training' Intervention Fails to Reduce Amyloid Pathologies or Cognitive Deficits in Transgenic Mouse Models of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1109-1121, 2017.
M. J. Andersson and Stone, J., “Best Medicine for Dementia: The Life-Long Defense of the Brain.”, J Alzheimers Dis, vol. 94, no. 1, pp. 51-66, 2023.
J. Andersson, Sundström, A., Nordin, M., Segersson, D., Forsberg, B., Adolfsson, R., and Oudin, A., “PM2.5 and Dementia in a Low Exposure Setting: The Influence of Odor Identification Ability and APOE.”, J Alzheimers Dis, vol. 92, no. 2, pp. 679-689, 2023.
C. - H. Andersson, Hansson, O., Minthon, L., Andreasen, N., Blennow, K., Zetterberg, H., Skoog, I., Wallin, A., Nilsson, S., and Kettunen, P., “A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1353-63, 2016.
A. G. Andrade, Bubu, O. M., Varga, A. W., and Osorio, R. S., “The Relationship between Obstructive Sleep Apnea and Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. s1, pp. S255-S270, 2018.
S. André, Ansciaux, E., Saidi, E., Larbanoix, L., Stanicki, D., Nonclercq, D., Elst, L. Vander, Laurent, S., Muller, R. N., and Burtea, C., “Validation by Magnetic Resonance Imaging of the Diagnostic Potential of a Heptapeptide-Functionalized Imaging Probe Targeted to Amyloid-β and Able to Cross the Blood-Brain Barrier.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1547-1565, 2017.
E. Andreadou, Pantazaki, A. A., Daniilidou, M., and Tsolaki, M., “Rhamnolipids, Microbial Virulence Factors, in Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 1, pp. 209-222, 2017.
E. Axelsson Andrén, Kettunen, P., Bjerke, M., Rolstad, S., Zetterberg, H., Blennow, K., Wallin, A., and Svensson, J., “Diagnostic Performance of Cerebrospinal Fluid Neurofilament Light Chain and Soluble Amyloid-β Protein Precursor β in the Subcortical Small Vessel Type of Dementia.”, J Alzheimers Dis, vol. 96, no. 4, pp. 1515-1528, 2023.
J. Andreotti, Dierks, T., Wahlund, L. - O., and Grieder, M., “Diverging Progression of Network Disruption and Atrophy in Alzheimer's Disease and Semantic Dementia.”, J Alzheimers Dis, vol. 55, no. 3, pp. 981-993, 2017.
S. J. Andrews, Das, D., Anstey, K. J., and Easteal, S., “Late Onset Alzheimer's Disease Risk Variants in Cognitive Decline: The PATH Through Life Study.”, J Alzheimers Dis, vol. 57, no. 2, pp. 423-436, 2017.

Pages